Fresenius Kabi
Lee Snyder possesses extensive experience in quality control and chemistry within the pharmaceutical industry. Notably, Lee served as Director of Quality Control at Fresenius Kabi from December 2014 to May 2023, leading QC Chemistry and Microbiology teams. Prior roles include Senior Manager of Chemistry, overseeing nearly 100 employees, and QC Chemistry Manager, where supervision extended to 5 supervisors and a Lead Scientist. Additional experience includes supervising manufacturing at Celgene, performing QC testing at Abraxis BioScience and Chesapeake Biological Labs, and executing organic synthesis as a Research Chemist at Starks Associates. Lee holds a PhD in Organic Chemistry from the University at Buffalo and a BS in Chemistry from Hobart and William Smith Colleges.
This person is not in any teams
This person is not in any offices
Fresenius Kabi
15 followers
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies.